J. Russell Hoverman

2.4k total citations
47 papers, 660 citations indexed

About

J. Russell Hoverman is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, J. Russell Hoverman has authored 47 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Economics and Econometrics, 24 papers in Public Health, Environmental and Occupational Health and 14 papers in Oncology. Recurrent topics in J. Russell Hoverman's work include Economic and Financial Impacts of Cancer (25 papers), Palliative Care and End-of-Life Issues (19 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). J. Russell Hoverman is often cited by papers focused on Economic and Financial Impacts of Cancer (25 papers), Palliative Care and End-of-Life Issues (19 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). J. Russell Hoverman collaborates with scholars based in United States, Canada and Ireland. J. Russell Hoverman's co-authors include Marcus A. Neubauer, Roy Beveridge, Michael Kolodziej, Carrie H. Colla, Jody S. Garey, Lonny Reisman, Dana S. Wollins, Richard L. Schilsky, Lowell E. Schnipper and Gary H. Lyman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

J. Russell Hoverman

43 papers receiving 618 citations

Peers

J. Russell Hoverman

PHEOH

ONCOL

PRM

GHP

Reka Pataky Canada

Riha Vaidya United States

Samuel R. Bozeman United States

Lorraine Warrington United Kingdom

M. Kelsey Kirkwood United States

David Goldsbury Australia

Anita O’Donovan Ireland

Tracy L. Wiedt United States

Emeline Aviki United States

Jeremy O’Connor United States

Reka Pataky Canada

J. Russell Hoverman

259 ×0.8

240 ×0.9

PHEOH

272 ×1.1

ONCOL

120 ×1.1

PRM

111 ×1.1

GHP

Citations per year, relative to J. Russell Hoverman J. Russell Hoverman (= 1×) peers Reka Pataky

Countries citing papers authored by J. Russell Hoverman

Since Specialization

Citations

This map shows the geographic impact of J. Russell Hoverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Russell Hoverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Russell Hoverman more than expected).

Fields of papers citing papers by J. Russell Hoverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Russell Hoverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Russell Hoverman. The network helps show where J. Russell Hoverman may publish in the future.

Co-authorship network of co-authors of J. Russell Hoverman

This figure shows the co-authorship network connecting the top 25 collaborators of J. Russell Hoverman. A scholar is included among the top collaborators of J. Russell Hoverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Russell Hoverman. J. Russell Hoverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoverman, J. Russell. (2022). A Life and a Death in Haiku. Journal of Clinical Oncology. 40(33). 3893–3896.

Hoverman, J. Russell, et al.. (2020). Hospice or Hospital: The Costs of Dying of Cancer in the Oncology Care Model. SHILAP Revista de lepidopterología. 1(1). 92–96. 10 indexed citations

Hoverman, J. Russell. (2020). Rethinking clinical oncology drug research in an era of value‐based cancer care: A role for chemotherapy pathways. Cancer Medicine. 9(15). 5306–5311. 1 indexed citations

Hoverman, J. Russell, et al.. (2019). Unraveling the high cost of end-of-life care: An oncology care model experience.. Journal of Clinical Oncology. 37(15_suppl). 11534–11534. 1 indexed citations

Hoverman, J. Russell, et al.. (2018). The institution of a white cell growth factor appropriate non-use policy for incurable metastatic solid tumors within a community oncology practice.. Journal of Clinical Oncology. 36(30_suppl). 33–33. 1 indexed citations

Wilfong, Lalan S., et al.. (2016). Changing physician compensation and implementing new technology to enhance pathways compliance.. Journal of Clinical Oncology. 34(7_suppl). 187–187. 1 indexed citations

Hoverman, J. Russell, et al.. (2016). Using a values assessment as a bridge to advance care planning: Results of 1286 patient reports.. Journal of Clinical Oncology. 34(26_suppl). 12–12. 1 indexed citations

Neubauer, Marcus A., et al.. (2016). Patient support call center: Interaction with the oncology clinic.. Journal of Clinical Oncology. 34(7_suppl). 84–84. 1 indexed citations

Neubauer, Marcus A., et al.. (2015). Improving Incidence of Code Status Documentation Through Process and Discipline. Journal of Oncology Practice. 11(2). e263–e266. 10 indexed citations

10.

Hoverman, J. Russell, et al.. (2014). Opening the Black Box: The Impact of an Oncology Management Program Consisting of Level I Pathways and an Outbound Nurse Call System. Journal of Oncology Practice. 10(1). 63–67. 42 indexed citations

11.

Hoverman, J. Russell, et al.. (2013). Defining Cancer Care Quality or Delivering Quality Cancer Care?. Journal of the National Comprehensive Cancer Network. 11(2). 121–124. 5 indexed citations

12.

Hoverman, J. Russell. (2013). If Palliative Care Is the Answer, What Is the Question?. Journal of Oncology Practice. 9(1). 55–56. 3 indexed citations

13.

Schnipper, Lowell E., Gary H. Lyman, Douglas W. Blayney, et al.. (2013). American Society of Clinical Oncology 2013 Top Five List in Oncology. Journal of Clinical Oncology. 31(34). 4362–4370. 89 indexed citations

14.

Hoverman, J. Russell, et al.. (2013). Science of quality: Communication, decision making, and behavior.. Journal of Clinical Oncology. 31(31_suppl). 22–22. 1 indexed citations

15.

Espirito, Janet L., Jody S. Garey, Matthew Clayton, et al.. (2012). A quality improvement program to increase performance with clinical oncology pathways.. Journal of Clinical Oncology. 30(34_suppl). 65–65. 1 indexed citations

16.

Muehlenbein, Catherine E., et al.. (2011). Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 2011. 1–5. 6 indexed citations

17.

Hoverman, J. Russell, Thomas H. Cartwright, Debra A. Patt, et al.. (2011). Pathways, Outcomes, and Costs in Colon Cancer: Retrospective Evaluations in Two Distinct Databases. Journal of Oncology Practice. 7(3S). 52s–59s. 83 indexed citations

18.

Mularski, Richard A., Margaret Campbell, Steven M. Asch, et al.. (2010). A Review of Quality of Care Evaluation for the Palliation of Dyspnea. American Journal of Respiratory and Critical Care Medicine. 181(6). 534–538. 57 indexed citations

19.

Neubauer, Marcus A., J. Russell Hoverman, Michael Kolodziej, et al.. (2010). Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting. Journal of Oncology Practice. 6(1). 12–18. 140 indexed citations

20.

Hoverman, J. Russell, et al.. (2004). Lung Cancer: A Cost and Outcome Study Based on Physician Practice Patterns. Disease Management. 7(2). 112–123. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact